Lynch Ryan
SEC insider (Form 3/4/5 filer). CIK 0001709271. Officer at CRESCENT BIOPHARMA, INC. (CBIO). 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 16, 2026. Located in WALTHAM, MA.
Companies Lynch Ryan has filed insider reports for
- CRESCENT BIOPHARMA, INC. (CBIO): Officer, See Remarks
Lynch Ryan
CIK: 0001709271
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CBIO
CRESCENT BIOPHARMA, INC.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 16, 2026CBIO
CRESCENT BIOPHARMA, INC.
SaleDirect240 shares at avg. $17.90$4K - Jun 22, 2026CBIO
CRESCENT BIOPHARMA, INC.
SaleDirect465 shares at avg. $17.99$8K - Dec 15, 2025CBIO
CRESCENT BIOPHARMA, INC.
AwardDirect8.4K shares- - Dec 15, 2025CBIO
CRESCENT BIOPHARMA, INC.
AwardDirect4K shares-
1-4 of 4 transactions